Results: HbA1c at diagnosis correlated to HbA1c at follow-up (p<0.001). There was a clear gender difference regarding HbA1c. Girls had higher values both at diagnosis and at follow-up (p<0.001). Girls also had lower BMI and pH at diagnosis than boys (p<0.001).
Introduction
Type 1 diabetes is the second most common chronic disease among children and adolescents in Sweden today, and its incidence has been increasing during the last decades (1, 2). Several studies have shown that higher glycated hemoglobin (HbA1c) level is correlated with a larger risk of complications later in life. (3) (4) (5) . Both treatmentrelated and patient-related factors affect metabolic control. Many studies show that a longer duration of disease is correlated with higher HbA1c (6) (7) (8) (9) . A gender-dependent difference in metabolic control has also been shown. Worse glycemic control (10) and a higher incidence of diabetic ketoacidosis ph < 7.3 (DKA), dyslipidemia and height problems in female patients are described in follow-up studies in western and eastern countries (11, 12) . Hochhauser et al showed that girls in the 6-12 age group presented with higher HbA1c levels compared with girls of other age groups and with boys (13) .
HbA1c during the initial years after diagnosis has been shown to be correlated with subsequent metabolic control. This was seen even among small children (14) .
Viswanathan et al showed that HbA1c levels at onset might predict future metabolic control (15) .
During recent decades, insulin treatment has improved and become more intensive. This has enabled us to individualize treatment. Insulin pumps are more common (16, 17), and patients are better able to self-monitor blood glucose (18, 19) . The correlation between intensive diabetes treatment and lower risk of complications has been clearly described (20, 21 ). Yet despite modern insulin treatment, many children and adolescents with type 1 diabetes do not achieve adequate HbA1c levels (22) , which puts them at risk of shortterm (23) and late complications (3, 5) . Both treatment-related and patient-related factors affect metabolic control. It is known that age, gender, duration of disease, number and frequency of insulin injections, (24) and frequency of self-monitoring of blood glucose (SMBG) are predictive factors (25) . Furthermore, center-specific factors such as a clear, low treatment target HbA1c value predict metabolic control (26) (27) .
In Sweden, as well as in other countries, outpatient attendance data are registered in quality registries (https//www.ndr.nu/ndr2/). This vast amount of data provides an opportunity to study aspects such as correlations between clinical variables and complications of the disease, and to identify vulnerable groups of patients. To increase our knowledge, we have to analyze these data to improve the quality of diabetes care.
Being able, as early as at diagnosis, to identify variables that can predict later outcome would help to better individualize treatment. By identifying patterns or groups of patients that need more intensive treatment, we could optimize the treatment of each patient.
The aim of this study was to explore the relationship between HbA1c at diagnosis, certain clinical variables and later metabolic control in a large unselected population of young patients.
Methods
Outpatient attendance data from all Swedish pediatric diabetes centers (n=43) are registered in the Swedish pediatric diabetes quality registry, SWEDIABKIDS Using data from 2010 in a linear regression analysis, HbA1c and BMI were used as dependent variables. In the logistic regression analysis, one group with HbA1c < 7.4 % (57mmol/mol) (n=1239), and one group with > 9.3 % (78 mmol/mol) (n=444) were compared. Children with BMI-SDS <25 th percentile (n=1017) were compared with children with BMI-SDS >75 th percentile (n=1073).
The BMI-SDS value for 2010 was divided in quartiles and thereafter compared with clinical parameters for the same year and at onset.
Results

Linear regression
Using data from 2010 with HbA1c as the dependent variable linear regression analysis showed that almost all variables influenced the HbA1c value (Table 1) . Female patients had a higher HbA1c level than male patients. When using BMI-SDS as dependent variable in the model, age and diabetes duration did not influence BMI-SDS significantly (Table 1) When only including children with diabetes, duration > 5 years and using data from 2010
(n = 1,725), the pattern was the same both for HbA1c and BMI-SDS.
The last part of table 1 shows clinical data at diagnosis and the influence of the variables on HbA1c at diagnosis. Having a mother and/or a father with high BMI was associated with higher HbA1c, whereas it was the opposite pattern for the patient, i.e. a low BMI at diagnosis was associated with high HbA1c. Girls had higher HbA1c and lower pH and BMI at diagnosis than boys.
Logistic regression
In the logistic regression model with the two groups of patients (HbA1c < 7.4%
(57mmol/mol) and HbA1c > 9.3% (78 mmol/mol)), including the clinical parameters, the results showed that HbA1c was positively associated with longer diabetes duration and higher age. It was also shown that girls had an increased risk of having high HbA1c (Table 2) .
Children with BMI-SDS < 25 percentile were compared with children with BMI-SDS > 75 percentile. Girls had a higher risk for BMI-SDS >75 percentile (OR = 1.65). Patients with BMI-SDS > 75 percentile reported a lower insulin U/kg than children with a low BMI-SDS (OR = 0.69) ( Table 3 ).
Other analysis
Clinical parameters in 2010 and at onset were compared in children and adolescents with different levels of yearly mean HbA1c values ( Table 2 ). Children with a high mean Boys in the highest HbA1c group > 9.3 % (78 mmol/mol)) had lower BMI than boys in the lower HbA1c groups. In contrast, girls in the highest HbA1c group also had higher BMI than girls in the lower HbA1c groups. Both girls and boys in the highest HbA1c group reported a higher insulin dose than patients in the lower HbA1c groups.
Discussion
This large study including an unselected patient cohort shows that girls have a higher
HbA1c level than boys at diagnosis of type 1 diabetes. It also shows that girls have a lower BMI and a lower pH than boys at diagnosis. As the higher HbA1c is correlated to a decrease in BMI and pH these findings indicate that the reason for higher HbA1c in girls at diagnosis is not due to their better tolerating high blood sugar. The girls present with more disease symptoms when they are diagnosed with type 1 diabetes. As yet, the reason for this is not understood, but the reason could be that we are less observant of symptoms in girls than in boys. Furthermore, the study shows that HbA1c at diagnosis predicts the level of metabolic control at follow-up years after diagnosis. This might be because, in the early stages, parents who are unaware that their child is becoming sick are not aware when they have poor metabolic control either. Children with a low year-mean HbA1c in 2010 had lower HbA1c at diagnosis than children with a high mean value in 2010. In many cases, patients at high risk of later complications can be identified at diagnosis. The study also shows that poor metabolic control persists over the years and that the initial years after diagnosis clearly predict later metabolic control. It is therefore very important never to let HbA1c increase, and if this should happen, intensive help should be offered to patients and their families to restore HbA1c to a reasonable level. Teenagers with poor metabolic control might not feel any incentive to improve their HbA1c as many complications of poor metabolic control are not seen until years later. However, families with structured daily routines might find it easier to achieve and retain good metabolic control (Table 4) .
Another finding in this study is that having a mother and/or father with high BMI is related to higher HbA1c at diagnosis. This, to our knowledge, has not previously been
shown, but might be due to socioeconomic factors.
Children with a high BMI during follow-up (>75 percentile) had higher blood pressure (systole) and a lower insulin dose (U/kg) (reported by the patient) than children with low BMI (<25 percentile). Female gender was related to high BMI. This might be due to higher estrogen levels in girls, which give an insulin resistance and therefore greater difficulties in achieving good metabolic control. As the combination of obesity and type 1 diabetes puts girls at a higher risk of later complications, it is important to identify the reason for this gender difference and to find ways to avoid a high BMI in girls. Health care providers as well as the patients themselves might be afraid to give adequate insulin doses according to the patient's weight and this gives the patients high HbA1c levels which further increase the risk of later complications.
Higher blood pressure was found among girls with high BMI. The girls in the highest BMI group also had higher mean HbA1c and a longer duration at follow-up than girls in The risk of later metabolic control and thereby the risk of late complications seems, in many cases, to be predictable at diagnosis. Quality registers offer a possibility to increase our knowledge about the gender difference observed at both diagnosis and follow-up.
Better early identification of patients at risk of poor metabolic control who therefore risk acute and later complications is important so that we can treat these patients intensively from the start to help them achieve and maintain good metabolic control. Gender (boy = 0, girl = 1) 1.32 1.02 -1.72 <0.001 Table 2 . Logistic regression. Two groups of children: one group with HbA1c < 7.4%
(57mmol/mol), n = 1,239 and one group with HbA1c> 9.3% (78 mmol/mol), n = 444. Table 3 . Logistic regression; comparing two groups of children, one group with BMI-SDS < 25
percentile and one group of children with BMI-SDS > 75 percentile.
